Nova Patents
AT460181T

Biodegradable immunomodulatory formulations and methods for use thereof

Abstract

This record has no abstract on file.

Term

Term ended

Expired 12 March 2021, 5.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

42 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
18830300United States of AmericaP
80235901United States of AmericaA
0107848United States of AmericaW

Members42

Family members, oldest first
DocumentOfficeKind
CA2402247A1CanadaA1
CA2402294A1CanadaA1
WO0168143A2World Intellectual Property Organization (WIPO)A2
WO0168144A2World Intellectual Property Organization (WIPO)A2
AU4562801AAustraliaA
AU4563101AAustraliaA
US2002055477A1United States of AmericaA1
WO0168143A3World Intellectual Property Organization (WIPO)A3
WO0168144A3World Intellectual Property Organization (WIPO)A3
EP1261377A2European Patent Office (EPO)A2
EP1261378A2European Patent Office (EPO)A2
US2003022852A1United States of AmericaA1
CA2456201A1CanadaA1
WO03015816A1World Intellectual Property Organization (WIPO)A1
US2003059773A1United States of AmericaA1
US2003129251A1United States of AmericaA1
JP2003526682AJapanA
JP2004502645AJapanA
EP1414490A1European Patent Office (EPO)A1
JP2005510462AJapanA
AU2001245631B2AustraliaB2
AU2001245628B2AustraliaB2
US7129222B2United States of AmericaB2
US7183111B2United States of AmericaB2
US7250403B2United States of AmericaB2
US2007258994A1United States of AmericaA1
AU2001281267B2AustraliaB2
EP2067487A2European Patent Office (EPO)A2
EP2067487A3European Patent Office (EPO)A3
EP1261377B1European Patent Office (EPO)B1
AT441436TAustriaT
ATE441436T1AustriaT1
DE60139764D1GermanyD1
EP1261378B1European Patent Office (EPO)B1
AT460181TThis recordAustriaT
ATE460181T1AustriaT1
DE60141508D1GermanyD1
US2011038896A1United States of AmericaA1
CA2402247CCanadaC
US8124590B2United States of AmericaB2
US2012121622A1United States of AmericaA1
US8669237B2United States of AmericaB2